Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2
Publication Number | Title | Priority Date |
---|---|---|
WO-2021219070-A1 | Degradation of bruton's tyrosine kinase (btk) by conjugation of btk inhibitors with e3 ligase ligand and methods of use | 2020-04-30 |
WO-2021159993-A1 | Inhibitors of interleukin-1 receptor associated kinase (irak) /fms-like receptor tyrosine kinase (flt3), pharmaceutical products thereof, and methods thereof | 2020-02-14 |
WO-2021127561-A1 | Isoindolinone and indazole compounds for the degradation of egfr | 2019-12-20 |
CN-112851664-A | Pyrazolo [1,5-a ] pyridine-3-nitrile compound and application thereof in medicine | 2019-11-12 |
WO-2021093720-A1 | Pyrazole[1,5-a]pyridine-3-nitrile compound and pharmaceutical use thereof | 2019-11-12 |
US-2021106588-A1 | Bicyclic heterocycles as fgfr inhibitors | 2019-10-14 |
WO-2021076602-A1 | Bicyclic heterocycles as fgfr inhibitors | 2019-10-14 |
WO-2021008455-A1 | Ret selective inhibitor, preparation method therefor and use thereof | 2019-07-12 |
CN-112209925-A | RET selective inhibitor and preparation method and application thereof | 2019-07-12 |
CN-114072404-A | RET selective inhibitor and preparation method and application thereof | 2019-07-12 |